Who Owns Arvinas Stock?
NASDAQ: ARVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 83.96%
- Held by insiders
- 7.80%
- Institutional holders
- 284
- Institutions 84.0%
- Insiders 7.8%
- Public and other 8.2%
Who owns Arvinas stock?
Institutional investors own about 84.0% of Arvinas's shares, spread across 284 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.80% of ARVN.
The largest institutional holders are Blackrock Inc. (11.79%), Vanguard Portfolio Management LLC (6.39%) and Shaw D.E. & Co., Inc. (5.42%). Together, the top 10 institutions control 49.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ARVN positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ARVN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 7.61M | 11.79% | +11.9% |
| Vanguard Portfolio Management LLC | 4.12M | 6.39% | +6.0% |
| Shaw D.E. & Co., Inc. | 3.50M | 5.42% | -3.9% |
| Pfizer Inc | 3.46M | 5.36% | 0.0% |
| Armistice Capital, LLC | 2.80M | 4.33% | +41.4% |
| Vanguard Capital Management LLC | 2.71M | 4.21% | +0.9% |
| Two Sigma Investments, LP | 2.57M | 3.99% | +40.5% |
| State Street Corporation | 2.20M | 3.40% | +20.1% |
| Geode Capital Management, LLC | 1.67M | 2.58% | +7.1% |
| Qube Research & Technologies Ltd | 1.59M | 2.47% | +32.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ARVN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.92M | 2.98% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 1.71M | 2.65% |
| iShares Trust-iShares Russell 2000 ETF | 1.53M | 2.37% |
| Vanguard Explorer Fund | 896.37K | 1.39% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 875.85K | 1.36% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 727.43K | 1.13% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 648.84K | 1.01% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 561.30K | 0.87% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 529.73K | 0.82% |
| iShares Trust-iShares Russell 2000 Value ETF | 501.70K | 0.78% |
Frequently asked questions
Who is the largest shareholder of Arvinas?
Blackrock Inc. is the largest institutional shareholder of ARVN, owning 11.79% of shares outstanding (7.61M shares) as of its latest 13F filing.
What percentage of Arvinas is owned by institutions?
Institutions own about 84.0% of ARVN shares and 91.1% of the public float.
How much of Arvinas do insiders own?
Insiders, such as officers and directors, own about 7.80% of ARVN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.